Treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-OHD3 plus pharmacological dose of 24,25(OH)2D3.

Source:http://linkedlifedata.com/resource/pubmed/id/7899583

Download in:

View as

General Info

PMID
7899583